| Target Price | $6.12 |
| Price | $1.17 |
| Potential |
423.08%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target TELA Bio Inc 2026 .
The average TELA Bio Inc target price is $6.12.
This is
423.08%
register free of charge
$7.35
528.21%
register free of charge
$2.02
72.65%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend TELA Bio Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the TELA Bio Inc stock has an average upside potential 2026 of
423.08%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 69.30 | 87.13 |
| 18.56% | 25.72% | |
| EBITDA Margin | -58.70% | -35.69% |
| 20.71% | 39.20% | |
| Net Margin | -54.60% | -38.41% |
| 31.60% | 29.66% |
7 Analysts have issued a sales forecast TELA Bio Inc 2025 . The average TELA Bio Inc sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an TELA Bio Inc EBITDA forecast 2025. The average TELA Bio Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 TELA Bio Inc Analysts have issued a net profit forecast 2025. The average TELA Bio Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.33 | -0.85 |
| 34.80% | 36.09% | |
| P/E | negative | |
| EV/Sales | 0.61 |
7 Analysts have issued a TELA Bio Inc forecast for earnings per share. The average TELA Bio Inc EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Citizens Capital Markets |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Nov 08 2024 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Oct 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
Citizens Capital Markets:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Nov 08 2024 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Oct 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


